Four things to know:
1. The company’s $3.55 million in revenue is a 57 percent jump from the first quarter of 2021.
2. Sales of its SiLO sacroiliac joint fusion device grew 26 percent over the fourth quarter of 2021. Its Zip device saw a 78.9 percent year-over-year increase in sales.
3. The company’s Dexa-C cervical implant was released on a limited basis and accounted for 7.9 percent of first-quarter sales.
4. “These results really demonstrate the strategy implemented over the past couple of years of focusing on proprietary products that help patients and doctors alleviate back pain in a minimally invasive manner,” CEO Trent Northcutt said in a news release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.